Deals & IPOs

Anthropic IPO investors are underwater — and locked-up shares loom

Anthropic (ANT) closed Friday at $88.30 — under its $111.50 opening price and barely above the $83 offering. A MarketWatch column flags billions in locked-up shares set to hit the market.

By Grace Kim

2 min read

The hidden catch in Anthropic’s IPO: Billions of locked-up shares are waiting in the wings
The hidden catch in Anthropic’s IPO: Billions of locked-up shares are waiting in the wingssergeitokmakov / pixabay

What's News

  • Anthropic (ANT) closed Friday at $88.30
  • IPO priced at $83; opened at $111.50 on day one
  • Column warns billions in locked-up shares could oversupply the market over the next year
  • Prospectus section on 'shares eligible for future sale' flagged the risk pre-trading

Anthropic shares closed Friday at $88.30 — a middling result for a hotly hyped IPO, and one that sits below both the $111.50 first-day opening price and barely above the $83 offering price set for initial buyers.

By Grace Kim

The math is blunt. If you bought at the open on day one, you're down roughly 21%. If you got the institutional allocation at $83, you're sitting on a gain of about 6% — thin comfort for a deal that was supposed to be the marquee tech listing of the cycle.

But the price action, argues a MarketWatch outside-the-box column, isn't even the real story. The real story is buried in a section of the prospectus that most investors never read: shares eligible for future sale.

What does the prospectus actually warn about?

Every IPO prospectus carries a section flagging how many shares are currently restricted and when they can hit the market. It's dry, mechanical, legal-mandated text. It's also, in Anthropic's case (ticker ANT), a flashing signal of oversupply, according to the column.

The concern is simple supply and demand. Billions of dollars' worth of shares are locked up in the hands of insiders, early employees and pre-IPO investors. Lockup expirations — typically staggered over the months after a listing — release those shares into the market. If holders decide to sell, the float expands fast, and the price absorbs the hit.

"A looming oversupply problem could weigh on the stock over the next year," the column's author writes.

That's not a hypothetical risk for people who bought the offering. It's a calendar item.

Why didn't investors see this?

Most investors never read an IPO prospectus, the column notes — but Anthropic's is one they "really should at least glance at." A quick look at the future-sales disclosure suggested the IPO could have issues once trading began.

In other words, the warning was public, printed and available before the first trade. The $111.50 open priced in optimism. The drift down to $88.30 by Friday's close repriced it.

What does the tape say so far?

Three numbers frame the early verdict:

  • $83 — the offering price paid by IPO allocators
  • $111.50 — the opening print on day one, the level retail buyers actually got
  • $88.30 — Friday's close

The gap between the second and third number is the damage. Anyone who chased the open is carrying a double-digit loss within the stock's first stretch of trading, while insiders still hold restricted stock valued in the billions.

The near-term question for ANT holders isn't whether the underlying business justifies a valuation — it's whether the market can absorb the wave of shares waiting for their lockups to expire without another leg down.

The takeaway: the prospectus told anyone willing to read it that supply was coming. Now the calendar, not the hype, sets the price.

Source: MarketWatch

Share this article:

More from Grace Kim

Grace Kim

Show full bio

Market editor covering people, launches and day-to-day practice in entrepreneurship, startups and venture funding at Business Bearings.

2,582 articles

Related articles

« Previous article